🇺🇸 Prazaxa in United States

1,508 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cerebral Infarction — 442 reports (29.31%)
  2. Cardiac Tamponade — 195 reports (12.93%)
  3. Fall — 178 reports (11.8%)
  4. Embolic Stroke — 120 reports (7.96%)
  5. Drug Ineffective — 108 reports (7.16%)
  6. Subdural Haematoma — 106 reports (7.03%)
  7. Cardiac Failure — 99 reports (6.56%)
  8. Cerebral Haemorrhage — 92 reports (6.1%)
  9. Renal Impairment — 86 reports (5.7%)
  10. Surgery — 82 reports (5.44%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Prazaxa approved in United States?

Prazaxa does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Prazaxa in United States?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.